Clinical Analysis of 12 Cases of Pulmonary Cryptococcosis

RUAN Yong-chun,ZHANG Chun-yi,WANG Wei

DOI: https://doi.org/10.13381/j.cnki.cjm.2011.02.020

2011-01-01

Abstract:Objective To improve the understanding of pulmonary cryptococcosis.Method Retrospective analysis was performed on the clinical features of 12 pulmonary cryptococcosis cases.Result A total of 12 patients were diagnosed,8 males and 4 females with an average age of(51.8±12.6)years old(ranged from 31 to 68 years).Six patients had underlying diseases,but no one had a history of close contact with birds.Ten patients had symptoms and 2 patients had signs.The main symptoms were cough(8 cases),expectoration(3 cases),chest pain(4 cases),and pyrexia(2 cases).Chest imaging findings:All the 12 cases had lesions located in the peripheral or subpleural,and the lesions were in the lower lobes in 10 cases.Radiologic manifestations showed multiform lesion such as nodules or masses in 10 cases,lobar consolidation in 1 case,and diffuse mixed pattern in 1 case;There were 3 cases complicated with air bronchogram,and 2 cases with cavity.Histopathological examination showed spherical spores in granulomatous inflammation.As to the treatment,5 patients underwent lobectomy and were given antifungal medicine such as fluconazole after operation,and the other 7 cases received antifungal medication of fluconazole or itraconazole only.Seven cases were fully cured,2 cases were improved,and 3 cases were lost to follow-up.Conclusion Pulmonary cryptococcosis can be seen among the immunocompetent people,and has little relation to history of contact with birds.It has no specific clinical manifestation,and pulmonary nodular or mass-type are the most common imaging findings.Diagnosis requires a combination of past history,clinical manifestations,chest imaging findings and related laboratory examinations,and confirmed diagnosis is according to histopathological examination.To treat the diseases,most of patients need antifungal drug application such as fluconazole,and surgery should be considered for persistent radiographic abnormalities and symptoms not responding to antifungal therapy.